Can clozapine (atypical antipsychotic) be used to reduce hemiballismus in a patient who has failed other treatments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clozapine for Hemiballismus

Clozapine can be effective for treating hemiballismus, particularly in patients who have failed standard dopamine receptor blockers like haloperidol, with clinical improvement typically observed within days at low doses (50 mg/day). 1

Evidence for Clozapine in Hemiballismus

The use of clozapine for hemiballismus is supported by case reports demonstrating rapid clinical response when traditional neuroleptics fail. In two documented cases, patients with hemiballismus who were nonresponsive to haloperidol for one month showed amelioration of ballistic movements within just a few days after starting clozapine at 50 mg/day. 1 This suggests clozapine may offer a valuable alternative mechanism of action beyond simple dopamine D2 blockade. 1

Treatment Algorithm for Hemiballismus

First-Line Approach

  • Start with standard dopamine receptor blockers (haloperidol or perphenazine) at low doses, titrating as tolerated until movements are controlled. 2
  • These agents have an established track record for suppressing choreic and ballistic movements. 2

Second-Line: Atypical Antipsychotics

  • If standard neuroleptics fail or are poorly tolerated, consider atypical antipsychotics including clozapine, risperidone, or olanzapine, which may have reduced risk of extrapyramidal side effects. 2
  • Olanzapine has demonstrated quantifiable reduction in hemiballistic movements, with one case showing upper extremity movements decreasing from 23.5 to 3.0 per 30-minute session during reaching tasks. 3
  • Clozapine at 50 mg/day is the specific dose documented to be effective, with response typically within days rather than weeks. 1

Address Underlying Etiology

  • In elderly patients with uncontrolled diabetes, aggressive glucose control is essential, as nonketotic hyperglycemia is an important reversible cause. 2, 4
  • Spontaneous improvement or remission occurs in many patients once the underlying cause is treated. 4
  • In vascular cases, the ballistic movements tend to subside over time, allowing drug withdrawal in many cases. 2

Clozapine-Specific Considerations

Monitoring Requirements

  • Mandatory weekly white blood cell counts for the first 6 months, then every 2 weeks thereafter due to agranulocytosis risk. 5
  • Monitor for dose-dependent seizure risk, particularly with rapid dose escalation. 5
  • Watch for sedation, hypersalivation, tachycardia, orthostatic hypotension, and weight gain. 5, 6

Advantages Over Traditional Neuroleptics

  • Clozapine causes minimal extrapyramidal side effects compared to haloperidol. 6
  • Its complex mechanism involving multiple neurotransmitter systems, including serotonergic antagonism, may explain efficacy when dopamine blockers alone fail. 5

Critical Pitfalls to Avoid

  • Do not dismiss hemiballismus in diabetic patients as purely neurological—check glucose levels and HbA1c, as hyperglycemia may be the sole reversible cause. 4
  • Do not escalate clozapine doses rapidly—the effective dose for hemiballismus (50 mg/day) is far lower than doses used for schizophrenia (200-300+ mg/day), minimizing seizure risk. 1, 7
  • Do not continue ineffective therapy for extended periods—if haloperidol shows no response after 2-4 weeks, switch to an atypical antipsychotic rather than continuing for months. 1
  • Do not overlook the need for supportive care—severe hemiballismus can cause exhaustion, injury, and metabolic complications requiring good supportive management. 2

References

Research

Clozapine in hemiballismus: report of two cases.

Clinical neuropharmacology, 1997

Research

Hemiballismus.

Current treatment options in neurology, 2005

Research

Olanzapine for the treatment of hemiballismus: A case report.

Archives of physical medicine and rehabilitation, 2005

Research

Hemiballismus in Uncontrolled Diabetes Mellitus.

Korean journal of family medicine, 2018

Guideline

Clozapine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Review and management of clozapine side effects.

The Journal of clinical psychiatry, 2000

Guideline

Clozapine Management in Complex Scenarios

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.